Imagine a super-plague resistant to antibiotics, or a smallpox variant resistant to vaccine.

That’s the contemporary bioweapons threat we must confront. The expanding COVID-19 epidemic has frayed a lot of nerves and caused the stock market to lose more than $1.5 trillion in the space of a few days. But that should not be our main concern. The minimal death rate for otherwise healthy individuals with the coronavirus means that we’ll get through this, likely without great suffering.